Achieve Life Sciences Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
ACHV Nasdaq 8731 http://achievelifesciences.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Achieve Life Sciences Inc

Achieve Life Sciences Announces Participation at H.C. Wainwright 1st Annual Mental Health Conference - Jun 21st, 2022 12:00 pm
Achieve Life Sciences Awarded Grant from the National Institutes of Health to Conduct Phase 2 Trial of Cytisinicline in Nicotine e-cigarette Users - Jun 1st, 2022 12:00 pm
Achieve Life Sciences Announces Participation at LD Micro Invitational Conference - May 26th, 2022 12:00 pm
36 of the Best Ideas Companies to Present at the Spring into Action - Best Ideas Investor Conference on May 16th - 20th, 2022 - May 16th, 2022 5:20 pm
Achieve Life Sciences Announces Participation at Best Ideas Virtual Investor Conference - May 13th, 2022 12:00 pm
ACHV: First Quarter 2022 Results - May 13th, 2022 10:30 am
Achieve Reports Financial Results for First Quarter 2022 and Provides Corporate Update - May 12th, 2022 8:00 pm
Health Check: How Prudently Does Achieve Life Sciences (NASDAQ:ACHV) Use Debt? - May 5th, 2022 6:59 pm
ACHV: Topline Data from ORCA-2 Smoking Cessation Trial - Apr 28th, 2022 9:22 am
Achieve Life Sciences Aces Pivotal Cytisinicline Study In Smoking Cessation - Apr 27th, 2022 1:40 pm
Achieve Life Sciences Announces Successful, Statistically Significant Smoking Cessation Results in Phase 3 ORCA-2 Clinical Trial of Cytisinicline in Adult Smokers - Apr 27th, 2022 12:00 pm
Achieve Life Sciences to Announce First Quarter Financial Results and Host Conference Call and Webcast on May 12, 2022 - Apr 21st, 2022 12:00 pm
Achieve Life Sciences Announces Cytisinicline Presentation at Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting - Mar 15th, 2022 12:00 pm
Achieve Life Sciences Announces Appointment of Dr. Vaughn Himes to Board of Directors - Mar 14th, 2022 12:00 pm
ACHV: 2021 Results: ORCA-3 Underway, ORCA-V1 Soon to Start - Mar 11th, 2022 1:06 pm
Achieve Life Sciences Announces Expansion of Manufacturing & Quality Operations Team and Granting of Inducement Award - Mar 11th, 2022 1:00 pm
Achieve Life Sciences Reports Financial Results for Fourth Quarter and Year-End 2021 and Provides Corporate Update - Mar 10th, 2022 1:00 pm
Achieve Life Sciences Announces Participation in March Investor Conferences - Mar 8th, 2022 1:00 pm
Achieve Life Sciences to Announce Fourth Quarter and Year-End 2021 Financial Results and Host Conference Call and Webcast on March 10, 2022 - Feb 24th, 2022 1:00 pm
ACHV: The Final Phase III Begins - Feb 4th, 2022 9:37 am